CD2000® Nattokinase shows significant potential in enhancing blood circulation and managing complications in diabetic individuals
Nattokinase (CD2000) shows significant potential in enhancing blood circulation and managing complications in diabetic individuals, primarily by improving fibrinolysis (breaking down blood clots) and suppressing inflammation. Studies indicate that CD2000 Nattokinase can be a useful adjunct to conventional diabetes care to reduce cardiovascular risks, which are elevated in diabetics.
Diabetic Retinopathy Potential: In studies with diabetic mouse models, CD2000 Nattokinase showed protective effects against microvascular damage in the retina, maintaining the blood-retinal barrier and reducing neuroinflammation.
CD2000 Nattokinase appears beneficial for diabetes management, particularly in improving metabolic health, reducing HbA1c, and lowering blood pressure, according to some studies. It may help manage complications by reducing Advanced Glycation End products (AGEs) and reducing blood clotting. However, it is not a cure and should not replace conventional treatment
Improved Metabolism: Studies indicate that nattokinase can lower fasting insulin and glucose levels, and improve insulin sensitivity.
Reduced Complications: Nattokinase shows promise in reducing diabetic complications, such as nephropathy (kidney disease) by reducing blood-induced damage.
Blood Sugar Management: It may help manage blood sugar levels through its effect on inhibiting inflammatory responses.
Retinal Protection: Research indicates it can help protect against diabetic retinopathy by reducing vascular leakage and damage in the eye.
While helpful for management, it is not a direct, primary treatment for diabetes. Always consult a healthcare professional for treatment of diabetis.